Norovirus Vaccine: Priorities for Future Research and Development.

Monitoring of clinical conditions after challenge revealed that signs and symptoms of NoV disease were less common and less severe in vaccine recipients than in controls, although differences did not reach statistical significance.

also in 111,027 other papers